Hepatitis Monthly

Published by: Kowsar

Distinct Toll-like Receptor 3 and 7 Expression in Peripheral Blood Mononuclear Cells From Patients with Chronic Hepatitis C Infection

Mahsa Motavaf 1 , 2 , Fatemeh Noorbakhsh 1 , Seyed Moayed Alavian 2 and Zohreh Sharifi 1 , 3 , *
Authors Information
1 Department of Microbiology, Islamic Azad University of Varamin-Pishva, Varamin, IR Iran
2 Department of Molecular Hepatology, Middle East Liver Disease Center (MELD), Tehran, IR Iran
3 Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, IR Iran
Article information
  • Hepatitis Monthly: April 01, 2014, 14 (4); e16421
  • Published Online: April 7, 2014
  • Article Type: Research Article
  • Received: November 26, 2013
  • Revised: January 25, 2014
  • Accepted: February 8, 2014
  • DOI: 10.5812/hepatmon.16421

To Cite: Motavaf M, Noorbakhsh F, Alavian S M, Sharifi Z. Distinct Toll-like Receptor 3 and 7 Expression in Peripheral Blood Mononuclear Cells From Patients with Chronic Hepatitis C Infection, Hepat Mon. 2014 ; 14(4):e16421. doi: 10.5812/hepatmon.16421.

Copyright © 2014, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Alavian S, Asl M, Lankarani K, Shahbabaie M, Bahrami Ahmadi A, Kabir A. Hepatitis C Infection in the General Population of Iran: A Systematic Review. Hepat Mon. 2009; 9(3): 211-23
  • 2. Vaidya SA, Cheng G. Toll-like receptors and innate antiviral responses. Curr Opin Immunol. 2003; 15(4): 402-7[DOI][PubMed]
  • 3. Mozer-Lisewska I, Sikora J, Kowala-Piaskowska A, Kaczmarek M, Dworacki G, Żeromski J. The incidence and significance of pattern-recognition receptors in chronic viral hepatitis types B and C in man. 2010; 58(4): 295-302[PubMed]
  • 4. Akira S, Takeda K. Toll-like receptor signalling. Nature Rev Immunol. 2004; 4(7): 499-511[PubMed]
  • 5. Schulz O, Diebold SS, Chen M, Näslund TI, Nolte MA, Alexopoulou L, et al. Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature. 2005; 433(7028): 887-92[PubMed]
  • 6. Duong FHT, Filipowicz M, Tripodi M, La Monica N, Heim MH. Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A. Gastroenterol. 2004; 126(1): 263-77[PubMed]
  • 7. Li K, Foy E, Ferreon JC, Nakamura M, Ferreon AC, Ikeda M, et al. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci U S A. 2005; 102(8): 2992-7[DOI][PubMed]
  • 8. Sumpter R, Jr., Loo YM, Foy E, Li K, Yoneyama M, Fujita T, et al. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J Virol. 2005; 79(5): 2689-99[DOI][PubMed]
  • 9. Atencia R, Bustamante FJ, Valdivieso A, Arrieta A, Rinon M, Prada A, et al. Differential expression of viral PAMP receptors mRNA in peripheral blood of patients with chronic hepatitis C infection. BMC Infect Dis. 2007; 7: 136[DOI][PubMed]
  • 10. Chang S, Kodys K, Szabo G. Impaired expression and function of toll-like receptor 7 in hepatitis C virus infection in human hepatoma cells. Hepatology. 2010; 51(1): 35-42[DOI][PubMed]
  • 11. Vollmer J, Rankin R, Hartmann H, Jurk M, Samulowitz U, Wader T, et al. Immunopharmacology of CpG oligodeoxynucleotides and ribavirin. Antimicrob Agents Chemother. 2004; 48(6): 2314-7[DOI][PubMed]
  • 12. Dolganiuc A, Garcia C, Kodys K, Szabo G. Distinct Toll-like receptor expression in monocytes and T cells in chronic HCV infection. World J Gastroenterol. 2006; 12(8): 1198-204[PubMed]
  • 13. Lehmann MH, Weber J, Gastmann O, Sigusch HH. Pseudogene-free amplification of human GAPDH cDNA. Biotechniques. 2002; 33(4): 766-70[PubMed]
  • 14. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001; 29(9)[PubMed]
  • 15. Pflugheber J, Fredericksen B, Sumpter R, Jr., Wang C, Ware F, Sodora DL, et al. Regulation of PKR and IRF-1 during hepatitis C virus RNA replication. Proc Natl Acad Sci U S A. 2002; 99(7): 4650-5[DOI][PubMed]
  • 16. Abe T, Kaname Y, Hamamoto I, Tsuda Y, Wen X, Taguwa S, et al. Hepatitis C virus nonstructural protein 5A modulates the toll-like receptor-MyD88-dependent signaling pathway in macrophage cell lines. J Virol. 2007; 81(17): 8953-66[DOI][PubMed]
  • 17. Thomas A, Laxton C, Rodman J, Myangar N, Horscroft N, Parkinson T. Investigating Toll-like receptor agonists for potential to treat hepatitis C virus infection. Antimicrob Agents Chemother. 2007; 51(8): 2969-78[DOI][PubMed]
  • 18. Imran M, Waheed Y, Manzoor S, Bilal M, Ashraf W, Ali M, et al. Interaction of Hepatitis C virus proteins with pattern recognition receptors. Virol J. 2012; 9: 126[DOI][PubMed]
  • 19. Mohammed KI, Adel LA, Ali-Eldin FA, Eladawy S. Expression of Toll like receptors 3 & 7 in peripheral blood from patients with chronic hepatitis C virus infection and their correlation with interferon-alpha. Egypt J Immunol. 2013; 20(1): 13-22[PubMed]
  • 20. Sato K, Ishikawa T, Okumura A, Yamauchi T, Sato S, Ayada M, et al. Expression of Toll-like receptors in chronic hepatitis C virus infection. J Gastroenterol Hepatol. 2007; 22(10): 1627-32[DOI][PubMed]
  • 21. Lee J, Wu CC, Lee KJ, Chuang TH, Katakura K, Liu YT, et al. Activation of anti-hepatitis C virus responses via Toll-like receptor 7. Proc Natl Acad Sci U S A. 2006; 103(6): 1828-33[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments